Gotoh Kenji, Hamada Nobuyuki, Kashiwagi Takahito, Hara Koyu, Watanabe Hiroshi
Department of Infection Control and Prevention, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, Fukuoka, 830-0011, Japan.
Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
Trop Med Health. 2025 Jun 13;53(1):80. doi: 10.1186/s41182-025-00763-z.
In cases of fever following international travel, medical evaluation should consider the prevalence of infectious diseases in the travel destination. However, there are instances where a definitive diagnosis cannot be made. Identifying these unknown pathogens is crucial for managing febrile returning travelers and as a model for the early detection of emerging infectious diseases. The aim of this study was identification of pathogens from febrile cases where fever was the primary symptom and no other specific clinical features were present.
Between 2008 and 2020, a total of 164 travelers visited Kurume University Hospital due to illness after returning from abroad. However, despite extensive testing, no definitive diagnosis was reached for 18 febrile travelers. Next-generation sequencing (NGS) was performed on eight samples (five whole blood, one serum, one cerebrospinal fluid, and one nasopharyngeal swab) collected from seven returning travelers with undiagnosed fever. Additionally, virus isolation using VeroE6 cells was conducted on two of these samples.
NGS detected human coronavirus OC43 (HCoV-OC43) genes in all eight samples. Of these, six samples contained only HCoV-OC43 genes, one sample contained both HCoV-OC43 and herpes simplex virus type 1 (HSV-1) genes, and one sample contained both HCoV-OC43 and mumps virus genes. Furthermore, conventional RT-PCR confirmed the presence of HCoV-OC43 genetic fragments in two of the eight samples.
Our findings suggest that before the COVID-19 pandemic, common coronaviruses such as HCoV-OC43 were a frequent cause of fever in returning travelers. If tropical infectious diseases, such as dengue fever and malaria, are excluded and the patient's general condition remains stable, outpatient follow-up is a viable option.
在国际旅行后出现发热的病例中,医学评估应考虑旅行目的地传染病的流行情况。然而,在某些情况下无法做出明确诊断。识别这些未知病原体对于管理发热的归国旅行者以及作为早期发现新发传染病的模型至关重要。本研究的目的是从以发热为主要症状且无其他特定临床特征的发热病例中鉴定病原体。
2008年至2020年间,共有164名旅行者在从国外返回后因病前往久留米大学医院就诊。然而,尽管进行了广泛检测,仍有18名发热旅行者未得到明确诊断。对从7名未确诊发热的归国旅行者采集的8份样本(5份全血、1份血清、1份脑脊液和1份鼻咽拭子)进行了下一代测序(NGS)。此外,对其中2份样本使用VeroE6细胞进行了病毒分离。
NGS在所有8份样本中均检测到人类冠状病毒OC43(HCoV-OC43)基因。其中,6份样本仅含有HCoV-OC43基因,1份样本同时含有HCoV-OC43和单纯疱疹病毒1型(HSV-1)基因,1份样本同时含有HCoV-OC43和腮腺炎病毒基因。此外,传统逆转录聚合酶链反应(RT-PCR)证实8份样本中有2份存在HCoV-OC43基因片段。
我们的研究结果表明,在2019冠状病毒病大流行之前,HCoV-OC43等常见冠状病毒是归国旅行者发热的常见原因。如果排除登革热和疟疾等热带传染病且患者一般状况保持稳定,门诊随访是一种可行的选择。